- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03835156
Introducing a New EEG Based Index for Monitoring Recall Under Sedation
This is a single centre prospective observational study that will investigate a new EEG based index in recognizing recall of anesthesia in sedated patients.
Awareness under general anesthesia is a dreadful complication. Various EEG-based technologies (such as BIS and others) were developed in order to identify this condition during anesthesia, using an EEG sticker on the forehead measuring the frontal EEG activity. However, these monitors might be inaccurate due to lack of sensitivity to various hypnotic agents as well as sensitivity to muscle activity, which might lead to report of deep anesthesia in the awake patient. Due to the very low prevalence of awareness under general anesthesia it is difficult to validate or invalidate the effectiveness of these monitors directly. Nevertheless, sedation often involves much greater prevalence of awareness, which permits to evaluate identification of recalled awareness with much humbler sample size.
The current available depth of anesthesia EEG based monitors are not effective in sedated patients since they are susceptible to muscle activity effect, which is present under sedation.
Based on the current literature in the field of electrophysiology the investigators have developed the anterior/ posterior (A/P) index (in the range of 0-100) for appreciating the anesthetic level. It is based on a comparison of anterior brain activity levels to posterior brain activity levels in response to anesthetic medication. The novelty of the index is stem from the fact that it is based on analyzing EEG data from only 4 electrodes covering the frontal and posterior brain activity. The investigators have shown in a proof of concept study performed in Rambam Hospital, Haifa, Israel that this index is not dependent on muscle activity thus is the only index that can identify recall in sedated patients.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Research group:
- Patients old 18-80 years
- ASA I-III criteria
Patients undergoing sedation for lithotripsy
Control groups -
- Control general anesthesia group - Patients ASA I-III criteria, undergoing general anesthesia for general surgery
- Control awake group - Awake healthy volunteers,
Exclusion Criteria:
Lack of informed consent, Age > 80 years, Age < 18 years pregnant women patients who do not comply with ASA I-III criteria.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification recall, using the new A/P index, in sedated patients
Time Frame: 2 years
|
In this new following study, the investigators suggest to repeat the proof of concept study performed in Rambam Hospital, Israel (NIH trial registration: NCT02938325), with an FDA approved EEG system, with much better signal-to-noise ratio in order to demonstrate the ability to monitor awareness at the 30-seconds resolution scale. The objective of this study will be to demonstrate that the A/P index, which is generated with an FDA approved EEG system, would relate to recall of awareness in sedation, with a better signal to noise ratio whereas a prefrontal based electrophysiological method (BIS) would not relate to recall. |
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification recall, using a prefrontal based electrophysiological method (BIS) in sedated patients
Time Frame: 2 years
|
Comparing the ability of BIS index to identify patients with recall under sedation, to the new A/P index
|
2 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REB 18-308
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Recall Phenomenon
-
Ain Shams UniversityCompletedAwareness, Anesthesia | Inhalation; Gas | Recall PhenomenonEgypt
-
Washington University School of MedicineThe Foundation for Barnes-Jewish HospitalCompletedExplicit Recall of Intra-operative EventsUnited States
-
Texas Tech UniversityCompleted
-
Washington University School of MedicineUniversity of Manitoba; University of Chicago; University of Michigan; American... and other collaboratorsCompletedExplicit Recall of Intra-Operative EventsUnited States, Canada
-
PictureRx, LLCNational Institute on Minority Health and Health Disparities (NIMHD)CompletedUnderstanding of Medication Instructions | Recall of Medication InstructionsUnited States
-
The University of Tennessee, KnoxvilleCompletedDietary Assessment | 24-hour Dietary Recall | Dietary Restraint | Social DesirabilityUnited States
-
University Medical Center GroningenRecruiting
-
University Hospital, GrenobleUniversity Hospital, RouenRecruitingRaynaud PhenomenonFrance
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of Central FloridaTerminatedRaynaud PhenomenonUnited States